LOCALLY ADVANCED PANCREAS CANCER
Clinical trials for LOCALLY ADVANCED PANCREAS CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED PANCREAS CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED PANCREAS CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Drug-Radiation combo tested for tough pancreatic tumors
Disease control Recruiting nowThis early-stage study is testing whether a new drug called XER-001, delivered directly to the small intestine, can be safely combined with precise radiation therapy for pancreatic cancer that hasn't spread. Researchers want to find the best dose and see if this combination helps…
Matched conditions: LOCALLY ADVANCED PANCREAS CANCER
Phase: PHASE1, PHASE2 • Sponsor: Xerient Pharma • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Scientists probe inside tumors during radiation treatment
Knowledge-focused Recruiting nowThis study aims to learn how radiation therapy changes the environment inside and around tumors in cervical and pancreatic cancer. Researchers will collect tissue samples, blood, and imaging data from 60 patients before, during, and after their standard radiation and chemotherapy…
Matched conditions: LOCALLY ADVANCED PANCREAS CANCER
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:25 UTC